Patents Assigned to Sinclair Pharmaceuticals, Ltd.
  • Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
    Patent number: 7262180
    Abstract: The present invention relates to compositions comprising telmesteine, glycyrrhetinic acid, and a proanthocyanidin, as well as methods for using such compositions in the treatment of an inflammatory condition of the skin including, but not limited to, atopic dermatitis(eczema), allergic contact dermatitis, seborrheic dermatitis, psoriasis, xerosis and atopia, as well as treatment of an inflammatory condition of mucosae and of an inflammatory condition in the eye. The present invention also relates to compositions comprising a proanthocyanidin, glycyrrhetinic acid and telmesteine, as well as methods for using such compositions in the treatment of an inflammatory condition of the skin including, but not limited to, atopic dermatitis, allergic contact dermatitis, seborrheic dermatitis, radiation dermatitis, psoriasis, xerosis and atopia, as well as treatment of an inflammatory condition of mucosae and of an inflammatory condition in the eye.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: August 28, 2007
    Assignee: Sinclair Pharmaceuticals, Ltd.
    Inventors: Marco Mastrodonato, Roberto Ciattini
  • Compositions and methods for the treatment or prevention of inflammation
    Publication number: 20040254143
    Abstract: The present invention relates to compounds containing as active ingredients hyaluronic acid and polyvinylpyrrolidone, for the treatment of inflammatory, ulcerative and painful conditions of moist epithelial surfaces such as mucositis, stomatitis, vestibulitis, aphthous ulcerations, and Behcet's syndrome.
    Type: Application
    Filed: July 15, 2004
    Publication date: December 16, 2004
    Applicant: Sinclair Pharmaceuticals, Ltd.
    Inventors: Marco Mastradonato, Gianluca Braguti
  • Compositions and methods for the treatment or prevention of inflammation
    Patent number: 6828308
    Abstract: The present invention relates to compounds containing as active ingredients hyaluronic acid and polyvinylpyrrolidone, for the treatment of inflammatory, ulcerative and painful conditions of moist epithelial surfaces such as mucositis, stomatitis, vestibulitis, aphthous ulcerations, and Behcet's syndrome.
    Type: Grant
    Filed: February 22, 2002
    Date of Patent: December 7, 2004
    Assignee: Sinclair Pharmaceuticals, Ltd.
    Inventors: Marco Mastradonato, Gianluca Braguti